Search
ASU/GHSU Consolidation
For the information about the consolidation, please visit: asughsu.org
May 2013 M T W T F S S « Feb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Archives
Tag Archives: Cancer
Scientists learn more about how inhibitory brain cells get excited
Scientists have found an early step in how the brain’s inhibitory cells get excited. A natural balance of excitement and inhibition keeps the brain from firing electrical impulses randomly and excessively, resulting in problems such as schizophrenia and seizures. However … Continue reading
Posted in Awards, Faculty, Groups, Medical College of Georgia, Neurological Disease, Research
Tagged AMPA, brain development, Cancer, Director of the Institute of Molecular Medicine and Genetics at the Medical College of Georgia at Georgia Regents University, Dr. Lin Mei, ErbB4, erbin, GABA, Georgia Research Alliance Eminent Scholar in Neuroscience, human development, inhibitory brain cells, interneurons, Nature Neuroscience, neuregulin-1, Neuron, neurotransmitter glutamate, NMDA receptor, protein erbin, pyramidal cells, Schizophrenia, stargazing, TARP gamma-2
1 Comment
$1.67 million grant supports possible cure methodology for deadly form of leukemia
Georgia Regents University cancer researchers are expanding the reach of an easy-to-use algorithm that could keep 30 percent of patients with a rare but deadly form of leukemia from dying within the first month of diagnosis. Continue reading
Posted in Cancer, Medical College of Georgia
Tagged APL, Cancer, Cheely, GHSU in the News, Hematology/Oncology, Jillella, Kota, leukemia, oncology
2 Comments
Multiple Appointments End, Multidisciplinary Care Begins at GHSU Cancer Center
For many cancer patients, it can feel like they’re spending as much time coordinating appointments and waiting for referrals as they are in getting treatment. Continue reading
Cancer cell line developed that is resistant to new cancer therapy
A cancer cell line that is resistant to one of the newest classes of cancer treatments has been developed by researchers who already are using it to determine what else to give patients when this happens. “The ultimate goal is … Continue reading
Genes identified that protect against heart damage from chemotherapy
A series of genes that protect cells from the powerful, common chemotherapeutic agent doxorubicin has been identified by researchers working to understand how the drug also can destroy the heart. "We found a series of genes that are very important … Continue reading
Dr. Horuzsko co-editors journal on HLA-G and cancer
Dr. Anatolij Horuzsko, reproductive immunologist at the Medical College of Georgia Center for Molecular Chaperone/Radiobiology and Cancer Virology, is co-editor of a special issue of the journal Seminars in Cancer Biology focusing on the relationship between cancer and a molecule … Continue reading
MCG goes tobacco-free Nov. 15
The Medical College of Georgia will be tobacco-free beginning Thursday, Nov. 15. The policy, which applies to all academic, research, MCG Health, Inc., and Physicians Practice Group facilities and property, takes effect on the 31st anniversary of the American Cancer … Continue reading
MCG Cancer Center selected for Association of American Cancer Institutes
The Medical College of Georgia Cancer Center has been selected for membership in the Association of American Cancer Institutes, an organization of the 90 leading cancer research centers in the United States. The MCG Cancer Center was recognized as the … Continue reading
Dr. Chang, expert in lung, esophageal surgery, joins faculty
Dr. Albert Shou-Yen Chang, a cardiothoracic surgeon specializing in benign and cancerous disease of the lungs and esophagus, has joined the faculty of the Medical College of Georgia. Dr. Chang comes to the MCG Department of Cardiothoracic and Vascular Surgery … Continue reading
Manmade protein shows promise for cancer, macular degeneration
Potentially blinding blood vessel growth in the cornea resulting from eye injury or even surgery can be reduced by more than 50 percent with a new manmade protein, researchers say. “We believe eventually we’ll be able to use this protein … Continue reading